Research progress of molecular targeting treatment in pancreatic cancer / 复旦学报(医学版)
Fudan University Journal of Medical Sciences
;
(6): 77-86, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-695769
ABSTRACT
Pancreatic cancer is the seventh most common cause of cancer deaths worldwide.Although more and more progress of oncotherapy has been achieved in recent years,very few progress has been achieved in pancreatic cancer.This review summarizes the molecular signaling pathway and relevant targeting drug,their recent clinical and experimental findings of this disease.It also presents the situation and future development of targeting treatment in pancreatic cancer.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Fudan University Journal of Medical Sciences
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS